Ontology highlight
ABSTRACT: Background and purpose
VBM is increasingly used in the study of neurodegeneration, and recently there has been interest in its potential as a biomarker. However, although it is largely "automated," VBM is rarely implemented consistently across studies, and changing user-specified options can alter the results in a way similar to the very biologic differences under investigation.Materials and methods
This work uses data from patients with HD to demonstrate the effects of several user-specified VBM parameters and analyses: type and level of statistical correction, modulation, smoothing kernel size, adjustment for brain size, subgroup analysis, and software version.Results
The results demonstrate that changing these options can alter results in a way similar to the biologic differences under investigation.Conclusions
If VBM is to be useful clinically or considered for use as a biomarker, there is a need for greater recognition of these issues and more uniformity in its application for the method to be both reproducible and valid.
SUBMITTER: Henley SM
PROVIDER: S-EPMC7964217 | biostudies-literature | 2010 Apr
REPOSITORIES: biostudies-literature
Henley S M D SM Ridgway G R GR Scahill R I RI Klöppel S S Tabrizi S J SJ Fox N C NC Kassubek J J
AJNR. American journal of neuroradiology 20091224 4
<h4>Background and purpose</h4>VBM is increasingly used in the study of neurodegeneration, and recently there has been interest in its potential as a biomarker. However, although it is largely "automated," VBM is rarely implemented consistently across studies, and changing user-specified options can alter the results in a way similar to the very biologic differences under investigation.<h4>Materials and methods</h4>This work uses data from patients with HD to demonstrate the effects of several u ...[more]